Complement-Based Drug Development Summit leaderboard
  • Wednesday, September 16, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Sreoshi Chatterjee
  • Page 34

Author

Sreoshi Chatterjee 452 posts 0 comments

Spectris plc acquires Concept Life Sciences

Jan 26, 2018
Spectris plc acquires Concept Life Sciences, the integrated drug discovery, development and analytical services and environmental consultancy company. Spectris has acquired the Concept…
Read More...

Liquidia proclaimed positive Phase1 and Preclinical results for LIQ861 for treatment of PAH

Jan 26, 2018
Late-stage clinical biopharmaceutical company, Liquidia Technologies focused on enhancing the performance of medicine by precisely engineering drug particles, today announced positive…
Read More...

Pixium Vision confirms human implantation and activation of PRIMA

Jan 26, 2018
Pixium Vision, Company committed to curating bionic vision systems ensuring revival of lost sight to patients, asserted the world’s first successful human implantation and activation of…
Read More...

COMPASS Trial results advocate Penumbra’s Frontline Thrombectomy approach for Acute Ischemic…

Jan 26, 2018
COMPASS Trial results suggest affirmative Penumbra;s approach to effective thrombectomy approach for acute ischemic stroke as part of the ADAPT (A DirectAspiration, First Pass …
Read More...

EPO extends Intent-to-Grant Notice to Onxeo for AsiDNA Patent

Jan 26, 2018
European Patent Office grants Intent-to-Grant notice to biotechnology company specializing in the development of innovative drugs in oncology, in particular against rare or resistant…
Read More...

EMA concedes Alnylam’s MAA for treatment of ATTR amyloidosis

Jan 26, 2018
European Medicines Agency asserted that Alnylam Pharmaceutical's application for Marketing Authorisation has been accepted for review of for patisiran, an investigational RNAi…
Read More...

Japan’s MHLW extended marketing and manufacturing authorization for Regeneron’s DUPIXENT

Jan 24, 2018
Japan's Ministry of health, labor and Welfare extended marketing and manufacturing authorization for Regeneron's DUPIXENT for the treatment of atopic dermatitis in adults not curbed by…
Read More...

CDE assents expansion of AGGRASTAT for CARDIOME

Jan 24, 2018
Chinese Center for Drug Evaluation has sanctioned an expansion of  expansion of the indications for Aggrastat for pharmaceutical company focused on commercializing patent-protected…
Read More...

SillaJen and ABL Europe extends strategic Manufacturing collaboration

Jan 24, 2018
Clinical-stage, biotherapeutics company, SillaJen committed to the development of oncolytic immunotherapy products for Cancer and ABL Europe company providing dedicated viral vector GMP…
Read More...

Ligand ventures into OmniAb platform license agreement with Ferring Pharmaceuticals

Jan 24, 2018
Ligand Pharmaceuticals asserted that it has forayed into a worldwide OmniAb platform license agreement with Ferring Pharmaceuticals. As per the terms of the agreement, Ferring…
Read More...
Prev Next
Amylin-Based Therapeutics Summit
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Novo Nordisk Rebrands as Novo With “Lasting Health Starts Now”
  • Schrödinger Launches Tectora With $55 Million Series A
  • CordenPharma Invests €80 Million in Injectable Manufacturing Expansion
  • FDA Approves Bayer’s HYRNUO for First-Line HER2-Mutated Lung Cancer
  • Encoded Therapeutics Raises $275 Million for Genetic Medicine Pipeline

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

FDA, Health Canada & Leading Biopharma Organizations…

Industry Leaders Convene in Boston as Registration Remains…

Who Is Shaping the Future of RNA-Targeted Drug Discovery?…

World ADC Awards 2026 Shortlist Announced, Recognizing…

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.